Please log in to view this page
Username
Password
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
A5320/V-HICS is an observational, prospective, long-term follow-up study in hepatitis C virus (HCV) monoinfected and HCV/HIV-1...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...
Many factors contribute to the development of aging-related conditions, including gastrointestinal (GI) diseases, such as...
